A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma
Conditions
- Nasopharyngeal Carcinoma
- Nasopharyngeal Cancer
- Nasopharynx Carcinoma
- Nasopharynx Cancer
Interventions
- DRUG: Cemiplimab
- DRUG: Fianlimab
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators